Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Nascent Biotech Inc (OP: NBIO )

0.0779 USD +0.0033 (+4.42%)
Official Closing Price Updated: 3:55 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 242,100
Open 0.0749
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0746
Today's Range 0.0710 - 0.0780
52wk Range 0.0456 - 0.1950
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Nascent Biotech Announces Initial Dosing Underway in Phase 1 Human Trial for Primary and Metastatic Brain Cancer
From ACCESSWIRE
Nascent Biotech Opens Phase 1 Human Trial to Evaluate Pritumumab as Treatment Option for Primary and Metastatic Brain Cancer
From ACCESSWIRE

Performance

YTD
+42.94%
+42.94%
1 Month
+29.62%
+29.62%
3 Month
+25.65%
+25.65%
6 Month
+19.85%
+19.85%
1 Year
-48.07%
-48.07%

More News

Read More
Nascent Biotech Earns US Patent for Crossing Blood-Brain Barrier
From ACCESSWIRE
Nascent Biotech Announces Successful Pritumumab In-Vitro Trial Data in Collaborative Covid-19 Treatment Study with Syracuse University
From ACCESSWIRE
Nascent Biotech Research Partner, Manhattan BioSolutions, to Present at the ACCESS CHINA Forum at the 2021 JPMorgan Healthcare Conference
From ACCESSWIRE
Nascent Biotech Receives Full IND Clearance to Begin Phase I Human Trials for Brain Cancer
From ACCESSWIRE
Nascent Biotech Announces Promising Covid-19 Invitro Study Results with Syracuse University Collaboration
From ACCESSWIRE
Nascent Biotech Announces Key Personnel Additions in Preparation for Coming Phase One Clinical Studies
From ACCESSWIRE
Nascent Biotech Continues to Reduce Liabilities by Over $2.0 Million Dollars
From ACCESSWIRE
Nascent Biotech Research Collaboration Partner, Manhattan BioSolutions, Receives Grant for Covid 19 Vaccine Studies.
From ACCESSWIRE
Nascent Biotech Inc Completes $740,000 Equity Round of Funding
From ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.